Tamoxifen Citrate (Nolvadex) ZPHC — 100 × 20 mg tablets
Tamoxifen Citrate (Nolvadex®) — Selective Estrogen Receptor Modulator (SERM) 100 film-coated tablets × 20 mg Purpose: competitive ER antagonist in breast tissue; core agent for PCT and estrogen-control research. PCT examples: 40 mg/day × 7–14 days → 20 mg/day × 14–28 days; supports LH/FSH rebound and endogenous testosterone. Estrogen management: useful for gynecomastia-prone protocols; can be combined with AIs when needed. Interactions/cautions: avoid concurrent strong CYP2D6 inhibitors; caution
Tamoxifen Citrate (Nolvadex) is a Selective Estrogen Receptor Modulator (SERM) that acts as a competitive estrogen receptor antagonist in breast tissue, making it a core agent for post-cycle therapy and estrogen-control protocols. This ZPHC product supplies 100 film-coated tablets of 20mg each.
By blocking estrogen receptor activity, Tamoxifen supports the recovery of the LH/FSH axis and endogenous testosterone production, and can be paired with an aromatase inhibitor when additional estrogen management is required.
Key Benefits
- Competitive estrogen receptor antagonist in breast tissue
- Supports LH/FSH rebound and recovery of endogenous testosterone
- Useful for gynecomastia-prone protocols
- Can be combined with AIs when additional estrogen control is needed
- Pharmaceutical-grade tablets with verified API purity
Bewertungen (0)
Noch keine Bewertungen.
